Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Construction Sub-Contractor Agrees to a False Claims Act Settlement

Nov 22, 2022 | False Claims Act, Fraud Investigations, Government Contract, Government Investigations

In fiscal year 2021, just under 90% of the government’s False Claims Act (FCA) recoveries came from within the healthcare industry.  The year prior, that figure was a bit lower, but still over 83%.  It is safe to say, then, that the “vast majority” of FCA...

Physician and Physician Practice Agree to Pay Over $2.6 Million to Resolve Alleged False Claims Act Violations

Nov 15, 2022 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud

Late last week, the United States Attorney’s Office for the District of Connecticut announced that a Connecticut physician and physician practice agreed to pay more than $2.6 million to resolve allegations that they violated the False Claims Act (FCA) by submitting...

Chilivis Grubman Settles False Claims Act Suit Mid-Trial

Nov 9, 2022 | Government Investigations, Health Care Fraud

On Friday, November 4, 2022, less than one week into a scheduled three-week trial, the attorneys at Chilivis Grubman, along with esteemed co-counsel, settled a lawsuit brought by Rebecca Hockaday (“Hockaday”) against firm client Athens Orthopedic Clinic (“AOC”),...

Carter Healthcare Agrees to Pay Millions to Resolve False Claims Act Allegations

Oct 20, 2022 | Government Investigations, Health Care Fraud

On October 18, the Department of Justice announced that for-profit home health provider Carter Healthcare LLC, along with its affiliates CHC Holdings and Carter-Florida (collectively Carter Healthcare), their President Stanley Carter, and Chief Operations Officer...

Pharmacist Faces up to 15 Years in Prison for Black-Market Prescription Drug Diversion Scheme

Oct 20, 2022 | Government Investigations

The DOJ just announced that Irina Sadovsky, owner and pharmacist-in-charge of Five Start RX, was convicted of conspiracy to commit health care fraud and conspiracy to engage in the unlicensed wholesale distribution of prescription drugs. Sadovsky now faces up to 15...

Pharmaceutical Giant Biogen Pays Nearly $1 Billion to Resolve False Claims Act Matter

Sep 29, 2022 | False Claims Act, Government Investigations, Health Care Fraud

On September 26, 2022, the Department of Justice (DOJ) announced that pharmaceutical giant Biogen, Inc. agreed to pay $900 million to resolve allegations that it violated the False Claims Act (FCA) by paying prescribing physicians kickbacks in exchange for prescribing...
« Older Entries
Next Entries »

Recent Posts

  • Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act
  • Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement
  • Condo Conversion Planned for 2460 Peachtree Road
  • HHS-OIG Expresses “Major Concerns” About Skin Substitutes
  • DOJ & DHS Partner on Trade Fraud Task Force

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group